Bravoxin 10 inj. susp. s.c.

Země: Belgie

Jazyk: angličtina

Zdroj: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Aktivní složka:

Clostridium perfringens type D (epsilon) toxoid ; Clostridium perfringens type C (beta) toxoid >= 18,2 IU/dose; Clostridium perfringens type B toxoid >= 18,2 IU/dose; Clostridium sordellii toxoïd >= 4,4 U/ml; Clostridium perfringens type A (alfa) toxoid >= 0,5 U/ml; Clostridium novyi toxoid >= 3,8 IU/ml; Clostridium septicum toxoid >= 4,6 ELISA U/dose; Clostridium chauvoei (inactivated) ; Clostridium haemolyticum toxoid >= 17,4 U/ml; Tetanus Toxoid >= 4,9 ELISA U/dose

Dostupné s:

Intervet International B.V.

ATC kód:

QI02AB01

INN (Mezinárodní Name):

Clostridium Haemolyticum Toxoid; Clostridium Tetani Toxoid; Clostridium Novyi Toxoid; Clostridium Chauvoei; Clostridium Perfringens; Clostridium Sordellii Toxoid

Léková forma:

Suspension for injection

Složení:

Clostridium Haemolyticum Toxoid; Clostridium Tetani Toxoid; Clostridium Novyi Toxoid; Clostridium Chauvoei; Clostridium Perfringens; Clostridium Sordellii Toxoid

Podání:

Subcutaneous use

Terapeutické skupiny:

cattle; sheep

Terapeutické oblasti:

Clostridium

Přehled produktů:

CTI code: 329576-02 - Pack size: 50 ml - Commercialisation status: NO - CNK code: 2572642 - Delivery mode: Medical prescription; CTI code: 329576-01 - Pack size: 20 ml - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 329576-03 - Pack size: 100 ml - Commercialisation status: NO - Delivery mode: Medical prescription

Stav Autorizace:

Commercialised: No

Datum autorizace:

2008-12-01